Medical Weight Loss in Phoenix, AZ

Most patients on this class of medication lose a clinically meaningful amount of weight over 12 to 16 months. The range varies widely based on starting weight, dose tolerance, lifestyle changes, and metabolic factors. Rather than quoting averages that may not apply to you, Stephen Noble, PA sets specific expectations during your evaluation based on your labs and medical history. We track your progress with regular follow-ups and adjust the plan based on how you’re responding.

That depends on your goals and your body’s response. Many patients benefit from 12 to 18 months of active treatment, followed by a maintenance phase. Because obesity is a chronic condition, some patients stay on medication long-term at a lower dose. Others transition to lifestyle-only maintenance with periodic check-ins. We discuss this based on your progress and lab results.

Most patients experience some weight regain after stopping. This is not a failure of willpower. It’s the biology of appetite regulation returning to its pre-treatment state. Patients who maintain exercise habits, work with a nutritionist, and stay engaged with medical follow-up tend to keep more of the weight off. Some patients restart medication if regain becomes significant.

Yes. Nausea is the most common, particularly during the first several weeks and after dose increases. It typically resolves as your body adjusts. Other common effects include mild GI changes (diarrhea, constipation), headache, and fatigue. Serious side effects are rare but include pancreatitis and gallbladder issues. We monitor for all of these at your follow-up visits.

Yes. Baseline labs are required. We check kidney function, liver function, A1C, thyroid function, and a lipid panel at minimum. Labs help us determine whether you’re a candidate, identify contraindications, and give us a baseline to measure metabolic improvement over time. We continue monitoring labs quarterly throughout treatment.

Possibly. This class of medication is also used to treat type 2 diabetes, so many diabetic patients are candidates. However, patients on insulin or certain diabetes medications may need dose adjustments to avoid low blood sugar. Thyroid disease is not a contraindication, but we screen thyroid function to rule out untreated hypothyroidism as a cause of weight gain. We review all of this during your evaluation.

The main differences are the depth of medical evaluation and the quality of ongoing monitoring. We require in-person visits, baseline lab work, and regular follow-up with lab monitoring. Online programs vary widely. Some are thorough. Others prescribe based on a questionnaire without labs, physical exam, or meaningful follow-up. For patients with straightforward cases, online may be fine. For patients with complex medical histories, in-person care is safer.

Every four to six weeks during the dose-escalation phase (the first 16 to 20 weeks). After reaching your target dose, visits shift to every eight to twelve weeks for ongoing monitoring. We also schedule lab draws quarterly to track metabolic markers.

Coverage varies significantly by plan. Some insurance plans cover physician-supervised weight loss programs and medications. Others do not. Compounded medications are typically not covered by insurance but are significantly less expensive than branded alternatives. Our team can help verify your coverage during your consultation.

Yes. Many patients pursue medical weight loss alongside other treatments. Hormone therapy and weight loss medication often complement each other because hormonal imbalances can affect metabolism, energy, and body composition. We coordinate treatment plans so everything works together rather than in isolation.